Qingdao Vland Biotech Co (SHSE:603739) Net Income From Continuing Operations : ¥107 Mil (TTM As of Mar. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Qingdao Vland Biotech Co Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Qingdao Vland Biotech Co's net income from continuing operations for the three months ended in Mar. 2024 was ¥17 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Mar. 2024 was ¥107 Mil.

Qingdao Vland Biotech Co Net Income From Continuing Operations Historical Data

The historical data trend for Qingdao Vland Biotech Co's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Qingdao Vland Biotech Co Net Income From Continuing Operations Chart

Qingdao Vland Biotech Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Net Income From Continuing Operations

Get a 7-Day Free Trial

89.39

122.31

150.10

85.41

102.86

Qingdao Vland Biotech Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Net Income From Continuing Operations	Get a 7-Day Free Trial															12.55	24.33	30.29	35.69	17.16

Qingdao Vland Biotech Co Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥107 Mil.

Qingdao Vland Biotech Co (SHSE:603739) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Qingdao Vland Biotech Co Ltd (SHSE:603739) » Definitions » Net Income From Continuing Operations

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 1318, Wangsha Road, Room 108, Enterprise Service Center, Chengyang District, Shandong, Qingdao, CHN, 266061

Website

http://www.vlandgroup.com

Qingdao Vland Biotech Co Ltd is a biotechnology company. The company is engaged in research and development of four main product categories which are enzymes, probiotics, vaccines and animal health products.

Executives

Chen Gang	Director
Jia De Qiang	Director
Cao Cheng	Director
Jiang Yong	senior management
Xu Yong	Supervisors

Qingdao Vland Biotech Co (SHSE:603739) Headlines

No Headlines